Is Final TNM Staging A Predictor for Survival in Locally Advanced Rectal Cancer after Preoperative Chemoradiation Therapy?
Authors:
- 6 June 2007
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 14 (10) , 2766-2772
Abstract
Neoadjuvant chemoradiation therapy has improved the local control rate and overall survival in locally advanced rectal cancers. The purpose of this retrospective study is to evaluate the correlation between the final pathologic stage and survival in these patients. Patients with biopsy-proven rectal carcinoma, pretreatment staging by magnetic resonance imaging such as T3 or T4 tumors, or node-positive disease were treated with preoperative concomitant 5-fluorouracil-based chemotherapy and radiation, followed by radical surgical resection. Clinical outcome with survival, disease-free survival, recurrence rate, and local recurrence rate were compared with each T and N findings using the American Joint Committee on Cancer Tumor-Node-Metastasis (TNM) staging system. A total of 248 patients were enrolled in this study. Overall survival and disease-free survival at 1, 3, and 5 years were 97.1, 92, and 89.9% and 87.5, 71.1, and 69.5%, respectively. Thirty-six patients (14.5%) had a pathologic complete response after neoadjuvant therapy. The recurrence rate was significantly different between the pathologic complete response group and residual group (5.6 vs 31.1%; P = .002). Five-year disease-free survival was significantly better in the complete response group than the residual tumor group (93 vs 66%; P = .0045). There was no statistical difference in survival or locoregional recurrence rate between these two groups. Posttreatment pathologic TNM stage is correlated to disease-free survival and tumor recurrence rate in locally advanced rectal cancer after preoperative chemoradiation. Also, pathologic complete response to neoadjuvant treatment has its oncologic benefit in both overall recurrence and disease-free survival.Keywords
This publication has 31 references indexed in Scilit:
- The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Prognostic significance of retrieved lymph nodes per specimenin resected rectal adenocarcinoma after preoperative chemoradiation therapyArchives of Medical Research, 2003
- Preoperative Radiochemotherapy and Sphincter-Saving Resection for T3 Carcinomas of the Lower Third of the RectumAnnals of Surgery, 2001
- Neoadjuvant Chemoradiation for Rectal Cancer: Analysis of Clinical Outcomes From a 13-Year Institutional ExperienceAnnals of Surgery, 2001
- Improved Overall Survival Among Responders to Preoperative Chemoradiation for Locally Advanced Rectal CancerAmerican Journal of Clinical Oncology, 2001
- Recent Advances in the Treatment and Outcome of Locally Advanced Rectal CancerAnnals of Surgery, 1999
- The National Cancer Data Base report on patterns of care for adenocarcinoma of the rectum, 1985-1995Cancer, 1998
- Improved Survival with Preoperative Radiotherapy in Resectable Rectal CancerNew England Journal of Medicine, 1997
- A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectumDiseases of the Colon & Rectum, 1997
- Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011JNCI: Journal of the National Cancer Institute, 1988